Remission in Rheumatoid Arthritis in the Asian-Pacific Region

• Conditions: Rheumatoid Arthritis
• Interventions: Other: observational study

• Registration Number: NCT03365856
• Lead Sponsor: Peking University People's Hospital

Brief Summary

This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in the Asian-Pacific area using different criteria of remission (DAS28, CDAI, SDAI, ACR/EULA remission criteria, RAPID3 and Clin28) and investigate the associated factors of remission in RA patients.

Detailed Description

Not available

Study Timeline

• Status Verified: 2017-12
• Study First Submitted: 2017-12-04
• Study First Submitted QC: 2017-12-06
• Last Update Submitted: 2017-12-06
• Study First Posted: 2017-12-07
• Last Update Posted: 2017-12-07
• Study Start: 2018-01-01
• Primary Completion: 2018-03-01
• Study Completion: 2018-06-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1500

Inclusion Criteria

• RA patients fulfilled the American College of Rheumatology 1987 criteria or the 2010 ACR/EULAR classification criteria.
• Patients aged > 18 years.

Exclusion Criteria

• No

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
RA patients	observational study	As routinary clinical practice and observational study

Primary Outcome Measures

Name	Time	Method
remission rate of RA patients in different countries in the Asian-Pacific area	12-24 months	according to the different criteria of clinical remission in RA patients